{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:22:42Z","timestamp":1769073762968,"version":"3.49.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:00:00Z","timestamp":1545350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02956","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T13:25:10Z","timestamp":1545398710000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Oral Administration of Human Polyvalent IgG by Mouthwash as an Adjunctive Treatment of Chronic Oral Candidiasis"],"prefix":"10.3389","volume":"9","author":[{"given":"Sigifredo","family":"Pedraza-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia I.","family":"M\u00e9ndez-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Laura","family":"Ventura-Ayala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Teresa","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"Lezana-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Bellanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12275-011-1064-7","article-title":"Candida albicans, a major human fungal pathogen","volume":"49","author":"Kim","year":"2011","journal-title":"J Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1128\/IAI.06146-11","article-title":"Interplay between Candida albicans and the mammalian innate host defense","volume":"80","author":"Cheng","year":"2012","journal-title":"Infect Immun."},{"key":"B3","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2174\/1568026618666180528121707","article-title":"Emerging virulence, drug resistance and future anti-fungal drugs for candida pathogens","volume":"18","author":"Srivastava","year":"2018","journal-title":"Curr Top Med Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in candida albicans and emerging non-albicans candida species","volume":"7","author":"Whaley","year":"2016","journal-title":"Front Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/21505594.2015.1004977","article-title":"Adaptive immune responses to Candida albicans infection","volume":"6","author":"Richardson","year":"2015","journal-title":"Virulence"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1038\/cti.2016.71","article-title":"Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity","volume":"5","author":"Okada","year":"2016","journal-title":"Clin Transl Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/ACI.0b013e328358cc0b","article-title":"Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis","volume":"12","author":"Puel","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2217\/imt.09.76","article-title":"Potential of anti-Candida antibodies in immunoprophylaxis","volume":"2","author":"Cabezas","year":"2010","journal-title":"Immunotherapy"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.1128\/IAI.71.9.5273-5279.2003","article-title":"A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities","volume":"71","author":"Moragues","year":"2003","journal-title":"Infect Immun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2741\/3533","article-title":"How the host fights against Candida infections","volume":"1","author":"Richardson","year":"2009","journal-title":"Front Biosci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e5392","DOI":"10.1371\/journal.pone.0005392","article-title":"Cassone: protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence","volume":"4","author":"Torosantucci","year":"2009","journal-title":"PLoS ONE"},{"key":"B12","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1128\/IAI.63.7.2714-2719.1995","article-title":"Antibody response that protects against disseminated candidiasis","volume":"63","author":"Han","year":"1995","journal-title":"Infect Immun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20050749","article-title":"A novel glyco-conjugate vaccine against fungal pathogens","volume":"202","author":"Torosantucci","year":"2005","journal-title":"J Exp Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1038\/s41598-017-02977-6","article-title":"Antibodies against a beta-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients","volume":"7","author":"Torosantucci","year":"2017","journal-title":"Sci Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fimmu.2014.00467","article-title":"Neutrophil-mediated phagocytosis of Staphylococcus aureus","volume":"5","author":"van Kessel","year":"2014","journal-title":"Front Immunol."},{"key":"B16","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/JB.98.3.996-1004.1969","article-title":"Interaction of Candida albicans with human leukocytes and serum","volume":"98","author":"Lehrer","year":"1969","journal-title":"J Bacteriol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1182\/blood-2014-01-551473","article-title":"Two independent killing mechanisms of Candida albicans by human neutrophils: evidence from innate immunity defects","volume":"124","author":"Gazendam","year":"2014","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0022-1759(98)00136-7","article-title":"A simple flow cytometry assay using dihydrorhodamine for the measurement of the neutrophil respiratory burst in whole blood: comparison with the quantitative nitrobluetetrazolium test","volume":"219","author":"Richardson","year":"1998","journal-title":"J Immunol Methods"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1086\/319679","article-title":"A whole blood bactericidal assay for tuberculosis","volume":"183","author":"Wallis","year":"2001","journal-title":"J Infect Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e256","DOI":"10.1016\/j.ijid.2009.11.005","article-title":"Bacille calmette-guerin infection and disease with fatal outcome associated with a point mutation in the interleukin-12\/interleukin-23 receptor beta-1 chain in two Mexican families","volume":"14","author":"Pedraza-Sanchez","year":"2010","journal-title":"Int J Infect Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3389\/fimmu.2017.01651","article-title":"Disseminated tuberculosis and chronic mucocutaneous candidiasis in a patient with a gain-of-function mutation in signal transduction and activator of transcription 1","volume":"8","author":"Pedraza-Sanchez","year":"2017","journal-title":"Front Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1574-695X.2006.00063.x","article-title":"Toxicity to Candida albicans mediated by human serum and peripheral blood mononuclear cells","volume":"46","author":"Bliss","year":"2006","journal-title":"FEMS Immunol Med Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4161\/21505594.2014.983015","article-title":"Vaccines in the treatment of invasive candidiasis","volume":"6","author":"Wang","year":"2015","journal-title":"Virulence"},{"key":"B24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/sj.bmt.1701560","article-title":"Fungal prophylaxis by reduction of fungal colonization by oral administration of bovine anti-Candida antibodies in bone marrow transplant recipients","volume":"23","author":"Tollemar","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/j.vaccine.2008.02.046","article-title":"In vitro and in vivo effectiveness of egg yolk antibody against Candida albicans (anti-CA IgY)","volume":"26","author":"Ibrahimel","year":"2008","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/00006454-200102000-00017","article-title":"Chronic mucocutaneous candidiasis","volume":"20","author":"Kirkpatrick","year":"2001","journal-title":"Pediatr Infect Dis J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/cid\/cit722","article-title":"Clinical features of Candidiasis in patients with inherited interleukin 12 receptor beta1 deficiency","volume":"58","author":"Ouederni","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/cid\/ciw020","article-title":"Ruxolitinib induces interleukin 17 and ameliorates chronic mucocutaneous candidiasis caused by STAT1 gain-of-function mutation","volume":"62","author":"Mossner","year":"2016","journal-title":"Clin Infect Dis."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02956\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T01:25:12Z","timestamp":1605749112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02956\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,21]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2018.02956"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02956","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,21]]},"article-number":"2956"}}